ABM Respiratory Care develops intelligent, clinically differentiated respiratory care solutions for use inside and outside the hospital. Its latest product, BiWaze® Clear, is a compact, battery-operated airway clearance system that combines lung expansion, high-frequency oscillations, and integrated aerosol delivery in a portable closed-loop dual-lumen circuit. The device is designed to enhance aerosol deposition deep in the lungs, improve mucus clearance, and shorten therapy time for home and hospital use. ABMRC plans to scale U.S. sales, invest in clinical research, and enhance patient engagement and digital health capabilities to support commercialization. The company recently completed an oversubscribed Series B financing, strengthening its financial position to accelerate market rollout of BiWaze® Clear. ABMRC is headquartered in Eagan, Minn. ABM Respiratory Care is a Singapore-based medical device company focused on developing novel integrated airway clearance and ventilation solutions. The company develops intelligent, clinically differentiated and innovative respiratory care products intended to help people breathe better inside and outside the hospital. ABM is led by CEO Vinay Joshi. The company raised US$10.3M in a Series A funding round to support its growth. The funding will help ABM advance its U.S. commercialization plans. ABM also announced the appointment of Peter H. Soderberg as Chairman of the company’s Board of Directors.

Total raised

$25M

Funding rounds

2

Latest round

Series B

Latest activity

Jun 2025